4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-18-019665
Chief Financial Officer sold 600,000 shares at $1.71 ($1,026,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian Chief Financial Officer | 2018-03-20 | Sale | −600,000 | $1.71 | $1,026,000 | 0 | D |
| Open-market sales · 600,000 sh · avg $1.71 · $1,026,000 | |||||||
Loading xslF345X03/a4.xml…